Business first reported 1h ago by Benzinga · updated 1h ago Teva Outlines Aggressive R&D Strategy with $7 Billion in Innovative Medicine Revenue by 2030 Photo: Benzinga ▲ Sign in to vote stories up Coverage 1 source · 1 report Chronological. Benzinga FIRST 1h ago Teva Outlines Aggressive R&D Strategy with $7 Billion in Innovative Medicine Revenue by 2030 Related stories Sports Merab Dvalishvili bloodied after alleged sneak attack by Usman Nurmagomedov in Abu Dhabi 2 sources Sports Leader, role model, extraordinary - how Kane's 'fairytale' came true 3 sources World Spain's first general strike in 14 years demands solutions to housing crisis 5 sources Business CoreWeave CEO says 'new political reality' after midterms won't slow buildout 2 sources Discussion 0 comments Sign in to join the discussion. ← Front page
Discussion 0 comments